ArticleClinical pharmacokinetics2023

Prognostic Value of Nivolumab Clearance in Non-Small Cell Lung Cancer Patients for Survival Early in Treatment.

Leila S Otten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.